image: coronaremedies.com Show Quick Read Summary is AI Generated. Newsroom Reviewed

Corona Remedies Ltd. which launched its initial public offering (IPO) on Monday, December 8, will conclude its subscription period on Wednesday.

The IPO was subscribed 9.33 times on Tuesday. The interest in the IPO was led by demand from Non-Institutional Investors who subscribed to the public issue over 26 times.

The grey market premium for the IPO was topping the 'Business and Finance' trending charts today, indicating strong investor demand.

The Ahmedabad-based pharmaceutical company develops, manufactures and markets products across multiple therapeutic segments, including women’s health, cardiology, pain management, and urology.

With the three-day bidding coming to a close, here’s all you ne

See Full Page